Prednisone/Prednisolone

Prednisone/Prednisolone 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。

正在招募患者的 Prednisone/Prednisolone 研究

• Prednisolone Treatment in Acute Interstitial Nephritis

  IV 期招募中丹麦NCT04376216

• Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  III 期招募中美国澳大利亚加拿大新西兰NCT03959085

• Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial

  II 期招募中美国NCT06841705

• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

  II 期招募中美国Brazil加拿大法国NCT05039619

• Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF

  III 期招募中法国NCT04702256

• Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（UPFRONT）

  IV 期招募中中国NCT07546097

• A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence

  II 期招募中中国NCT07087314

• A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

  II 期 / III 期招募中美国Argentina澳大利亚ChileNCT07634471

• Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares

  IV 期招募中加拿大NCT07245732

• Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis

  III 期招募中法国NCT05674994

• A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  III 期招募中美国Argentina澳大利亚奥地利NCT06952803

• A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

  II 期 / III 期招募中美国Argentina澳大利亚比利时NCT07412470

• Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune Thrombocytopenia

  IV 期招募中中国NCT07788456

• Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

  II 期招募中美国NCT02784210

• A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

  II 期招募中美国NCT05800366

• A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

  III 期招募中美国澳大利亚Brazil加拿大NCT06911502

• Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD

  III 期招募中中国NCT05921305

• A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  III 期招募中美国澳大利亚奥地利比利时NCT06091865

• Evaluation of the Efficacy and Safety of Darolutamide + ADT Combined With Low-dose Docetaxel in mHSPC

  II 期招募中中国NCT07503379

• A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

  II 期招募中美国中国法国德国NCT07005154

• A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  II 期招募中美国澳大利亚加拿大Puerto RicoNCT06124157

• Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis

  IV 期招募中美国NCT07258771

• Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017

  III 期招募中澳大利亚奥地利Czechia德国NCT03643276

• A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

  III 期招募中美国澳大利亚奥地利加拿大NCT06585774

本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。